Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety of intravenously infused allogeneic umbilical cord-derived mesenchymal stem cells for systemic lupus erythem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Lupus | Phase 1 | Status: RECRUITING